Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

Researchers from Karolinska Institutet found a high number of the so-called natural killer cells, an important anti-lymphoma cell, in samples from patients with cutaneous lymphoma. However, the cells were immature and less active. A future therapy could be to restore their function locally. The study was published in Frontiers in Immunology.